BEAM Q3 2025 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-32.0% YoY

Gross Profit

-$100M-1031.9% margin

Operating Income

-$127M-1307.6% margin

Net Income

-$113M-1162.4% margin

EPS (Diluted)

$-1.10

QoQ Revenue Growth

+14.6%

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$86M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$345M

Stockholders' Equity

$966M

Cash & Equivalents

$268M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$14M	-32.0%
Gross Profit	-$100M	-$80M	-25.1%
Operating Income	-$127M	-$107M	-19.1%
Net Income	-$113M	-$97M	-16.6%